
Company valuation, historical trends, and peer comparisons.
According to Vigil Neuroscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 349.63M. This represents a change of 157.15% compared to the average of 135.97M of the last 4 quarters.
The mean historical Enterprise Value of Vigil Neuroscience, Inc. over the last ten years is 187.14M. The current 349.63M Enterprise Value has changed 86.83% with respect to the historical average. Over the past ten years (40 quarters), VIGL's Enterprise Value was at its highest in in the June 2025 quarter at 349.80M. The Enterprise Value was at its lowest in in the June 2022 quarter at -75735868.42.
Average
187.14M
Median
209.64M
Minimum
43.06M
Maximum
333.39M
Discovering the peaks and valleys of Vigil Neuroscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 333.39M
Minimum Annual Increase = -55.78%
Minimum Annual Enterprise Value = 43.06M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 43.06M | -53.55% |
| 2023 | 92.71M | -55.78% |
| 2022 | 209.64M | -18.40% |
| 2021 | 256.91M | -22.94% |
The current Enterprise Value of Vigil Neuroscience, Inc. (VIGL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
115.13M
5-year avg
187.14M
10-year avg
187.14M
Vigil Neuroscience, Inc.’s Enterprise Value is less than Edgewise Therapeutics, Inc. (4.04B), greater than PepGen Inc. (153.46M), less than Pharvaris N.V. (1.78B), greater than Rallybio Corporation (-5680651.00), greater than Entrada Therapeutics, Inc. (140.05M), less than Tyra Biosciences, Inc. (1.20B), greater than Xilio Therapeutics, Inc. (-77293181.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 4.04B | $4.10B | |
| 153.46M | $160.13M | |
| 1.78B | $2.35B | |
| -5680651.00 | $85.01M | |
| 140.05M | $190.79M | |
| 1.20B | $1.27B | |
| -77293181.00 | $52.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vigil Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vigil Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vigil Neuroscience, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vigil Neuroscience, Inc. (VIGL)?
What is the 3-year average Enterprise Value for Vigil Neuroscience, Inc. (VIGL)?
What is the 5-year average Enterprise Value for Vigil Neuroscience, Inc. (VIGL)?
How does the current Enterprise Value for Vigil Neuroscience, Inc. (VIGL) compare to its historical average?